If you can see this message, your browser does not support canvas and needs an update. Sorry. :(
Wednesday, December 12, 2018 
Market Status: CLOSE
About us and Governance Investor Relations Contact
Advanced search

Market News

Med Life S.A. - M

Prospectus share capital increase

Release Date: 11/15/2017 6:37:29 PM

IRIS Code: 1A407

No. 17/15.11.2017


According to the Regulation CNVM No. 1/2006


Report date: 15.11.2017

Name of the issuing entity: MED LIFE S.A.

Headquarters: Calea Grivitei no. 365, district 1, Bucharest, Romania

Telephone number/ fax: 0374180470

Sole registration code: 8422035

Registration number in the Trade Registry: J40/3709/1996

Subscribed and paid-up share capital: 5,023,000 RON

The regulated market on which the issued securities are traded: Bucharest Stock Exchange, Premium Category


Important events to be reported:


Approval by the Financial Supervisory Authority and publication of the Proportionate disclosure prospectus for the rights issue as a result of the share capital increase by Med Life S.A.

with the observance of the pre-emption rights


Read the Proportionate Disclosure Prospectus before subscribing!

Med Life S.A. informs its investors that the Financial Supervisory Authority approved the Proportionate disclosure prospectus for the rights issue in respect of a maximum number of 2,600,000 new shares to be issued as a result of the share capital increase through cash contribution, by way decision no. 1617 of 15.11.2017 (the "Proportionate Disclosure Prospectus"). The level of disclosure of the Proportionate Disclosure Prospectus is proportionate to this type of issue.

The Proportionate Disclosure Prospectus, together with the other documents that Med Life S.A. is required to make available to the investors, are published on the website of Med Life S.A. at http://medlifeinternational.com > Investors Relations.

Key elements of the issue:

-          Maximum number of offered shares: 2,600,000 new shares;

-          Pre-emption right exercise period: 16 November 2017 – 18 December 2017;

-          Number of Pre-emption Rights necessary to subscribe one new share: 7.72769 Pre-emption Rights;

-          Record date: 27.10.2017. The issue of new shares as a result of subscriptions in the Pre-emption right exercise period is addressed exclusively to the persons registered in the shareholders registry of Med Life S.A. as shareholders on the record date;

-          Maximum price per share (subscription price): 36 RON/new share;

-          Final price per share: will be announced at the latest on the first Business Day following the last date of the subscription period and shall be less than or equal to the Maximum Price;

-          Private placement: the new shares not subscribed during the Pre-emption right exercise period shall be offered for subscription in a private placement exempted from the obligation to prepare and publish a prospectus;

-          Tradability: The Pre-emption Rights are not tradeable. After the closing of the exercise period for the pre-emption rights and of the private placement, Med Life S.A. will apply for the admission of the new shares allocated in the share capital increase to trading on the regulated market operated by the Bucharest Stock Exchange.

The Proportionate Disclosure Prospectus is also available on the website of SSIF Tradeville S.A., www.tradeville.eu, and on the website of Bucharest Stock Exchange www.bvb.ro.


The approval stamp applied on the public offering prospectus does not represent a guarantee or any type of appraisal by the Financial Supervisory Authority as regards the opportunities, advantages or disadvantages, profits or risks involved by the transactions to be concluded following the acceptance of the public offer subject of the approval decision. The approval decision certifies only that the prospectus complies with the requirements of the law and of the norms adopted in its application.



Mihail Marcu

Chairman of the Board of Directors   




Information provided by IRIS, the news platform of the Bucharest Stock Exchange.


Bucharest Stock Exchange ("BVB") is not responsible for the content of this News item. Issuers whose financial instruments are traded on markets operated by BVB are required to report in accordance with current legal and regulatory provisions. BVB publishes these Reports as market administrator, appointed by ASF. When, for investors’ information, Reports are published, either signed by different persons, or with conflicting information, legal liability lies fully with the signatories. BVB disclaims any obligation or responsibility towards issuers or third parties, regarding the reality, completeness and accuracy of information provided by them and distributed by BVB. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.

©2016 Bucharest Stock Exchange. All rights reserved